Sanara MedTech, Inc. (SMTI)
Stock Price:
$24.69 USD
-1.10 (-4.27%)
Updated Aug 7, 2020 4:00 PM EDT - End of day
Key Info
| Market Cap |
153.16M |
| Revenue (ttm) |
12.80M |
| Net Income (ttm) |
-4.49M |
| Shares Out |
6.20M |
| EPS (ttm) |
-1.06 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
Aug 7, 2020 |
| Last Price |
$24.69 |
| Previous Close |
$25.79 |
| Change ($) |
-1.10 |
| Change (%) |
-4.27% |
| Day's Open |
25.55 |
| Day's Range |
24.69 - 26.05 |
| Day's Volume |
2,821 |
| 52-Week Range |
4.73 - 26.49 |
More Stats
| Market Cap |
153.16M |
| Enterprise Value |
149.71M |
| Earnings Date (est) |
n/a |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
6.20M |
| Float |
1.33M |
| EPS (basic) |
-1.43 |
| EPS (diluted) |
-1.06 |
| FCF / Share |
-0.84 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
n/a |
| FCF Yield |
n/a |
| Payout Ratio |
n/a |
| Shares Short |
n/a |
| Short Ratio |
n/a |
| Short % of Float |
n/a |
| Beta |
2.23 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| P/FCF Ratio |
n/a |
| PS Ratio |
11.96 |
| PB Ratio |
20.62 |
| Revenue |
12.80M |
| Operating Income |
-4.38M |
| Net Income |
-4.49M |
| Free Cash Flow |
-4.00M |
| Net Cash |
3.45M |
| Net Cash / Share |
0.56 |
| Gross Margin |
82.45% |
| Operating Margin |
-34.20% |
| Profit Margin |
-35.10% |
| FCF Margin |
-31.21% |
| ROA |
-42.82% |
| ROE |
-155.03% |
| ROIC |
-173.60% |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Summary
Analyst Ratings (0)
| Buy |
0 |
| Overweight |
0 |
| Hold |
0 |
| Underweight |
0 |
| Sell |
0 |
*No analysts have provided price targets for this stock.
Financial Performance
Financial numbers in millions USD.
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|
| Revenue | 11.77 | 5.84 | 6.30 | 5.51 | 3.37 | 2.63 | 1.73 | 1.17 | 2.21 | 0.91 |
| Revenue Growth | 101.56% | -7.41% | 14.47% | 63.33% | 28.09% | 52.49% | 47.11% | -46.89% | 142.71% | - |
| Gross Profit | 10.56 | 5.33 | 5.50 | 4.56 | 2.48 | 1.83 | 0.93 | 0.38 | 1.41 | 0.37 |
| Operating Income | -2.74 | -0.50 | 0.12 | -0.27 | -0.96 | -2.06 | -2.93 | -5.42 | -5.01 | -2.48 |
| Net Income | -2.81 | -0.60 | 0.33 | -0.42 | -1.34 | -2.28 | -4.15 | -1.85 | -12.74 | -6.64 |
| Shares Outstanding | 2.13 | 2.17 | 1.11 | 1.09 | 1.07 | 0.88 | 0.78 | 0.63 | 0.55 | 0.36 |
| Earnings Per Share | -1.32 | - | - | -1.00 | -2.00 | -3.00 | -5.00 | -3.00 | -23.00 | -19.00 |
| Operating Cash Flow | -2.17 | 0.28 | -0.14 | 0.41 | -1.20 | -1.69 | -1.82 | -1.23 | -0.34 | -1.49 |
| Capital Expenditures | -0.18 | -0.01 | -0.04 | - | -0.01 | -0.01 | -0.03 | - | - | - |
| Free Cash Flow | -2.35 | 0.27 | -0.18 | 0.41 | -1.21 | -1.69 | -1.85 | -1.23 | -0.34 | -1.49 |
| Cash & Equivalents | 6.61 | 0.18 | 0.46 | 0.83 | 0.18 | 0.52 | 0.04 | 0.05 | 0.96 | 0.06 |
| Total Debt | 2.10 | - | 1.20 | 1.62 | 1.82 | 1.61 | 1.70 | 2.42 | 1.37 | 2.58 |
| Net Cash / Debt | 4.51 | 0.18 | -0.74 | -0.78 | -1.64 | -1.08 | -1.66 | -2.37 | -0.40 | -2.52 |
| Assets | 11.12 | 1.71 | 2.22 | 2.17 | 1.39 | 1.50 | 0.98 | 1.39 | 3.83 | 6.78 |
| Liabilities | 4.72 | 1.12 | 2.12 | 2.59 | 2.66 | 2.32 | 3.45 | 5.20 | 7.69 | 6.23 |
| Book Value | 6.61 | 0.59 | 0.10 | -0.42 | -1.27 | -0.83 | -2.47 | -3.81 | -3.86 | 0.56 |
Numbers in millions USD, except per-share numbers.
Company Details
| Full Name |
Sanara MedTech, Inc. |
| Country |
United States |
| Employees |
36 |
| CEO |
J. Michael Carmena |
Stock Information
| Ticker Symbol |
SMTI |
| Stock Exchange |
US OTC |
| Sector |
Healthcare |
| Industry |
Medical Care Facilities |
| Unique Identifier |
OTCMKTS: SMTI |
Description
Sanara MedTech Inc. develops, markets, and distributes biotechnology products to physicians, hospitals, and clinics in the United States. It offers HemaQuell, a resorbable bone hemostat for bone healing; and CellerateRX surgical for healing. The company was formerly known as WNDM Medical Inc. and changed its name to Sanara MedTech Inc. in May 2019. Sanara MedTech Inc. was founded in 1982 and is based in Fort Worth, Texas.